(Reuters)-Independent advisors to the US Centers for Disease Control and Prevention will meet later this month to develop recommendations for booster doses. Modana (NASDAQ :) Inc and Johnson & Johnson (NYSE :) COVID-19 vaccine.
The October 20-21 meeting is scheduled a week after a US Food and Drug Administration adviser considers the need for boosters of the two vaccines.
The CDC Committee, called the Immunization Implementation Advisory Board, will also discuss the COVID-19 vaccine for children on November 2 and 3, officials said a spokesman for the authorities.
Pediatrics meetings are also held by FDA advisors Pfizer Inc (NYSE :) COVID-19 vaccine for children aged 5 to 11 years.
Pfizer said Thursday that the company and its partner BioNTech SE (NASDAQ :) have requested US regulators to permit emergency use of the COVID-19 vaccine for children aged 5 to 11 years.
Fusion media Alternatively, anyone involved in Fusion Media will not be liable for any loss or damage resulting from relying on the data, quotes, charts, trading signals and other information contained on this website. Please be fully informed about the risks and costs associated with financial market transactions. This is one of the most risky forms of investment possible.
US CDC Advisor Review Moderna, J & J COVID-19 Booster Shots This Month
https://www.investing.com/news/stock-market-news/us-cdc-advisers-to-meet-this-month-to-discuss-moderna-jj-covid19-vaccine-boosters-2639036 US CDC Advisor Review Moderna, J & J COVID-19 Booster Shots This Month